- Filed
- Jun 14, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Jun 14, 2021 | 11.13M sh |
| Current Liabilities | Q2 2021 · Apr 30, 2021 | $44.42K |
| Current Liabilities | Q2 2021 · Oct 31, 2020 | $26.47K |
| Total Liabilities | Q2 2021 · Apr 30, 2021 | $55.72K |
| Total Liabilities | Q2 2021 · Oct 31, 2020 | $37.77K |
| Current Assets | Q2 2021 · Apr 30, 2021 | $814.28K |
| Current Assets | Q2 2021 · Oct 31, 2020 | $1.05M |
| Total Assets | Q2 2021 · Apr 30, 2021 | $1.6M |
| Total Assets | Q2 2021 · Oct 31, 2020 | $1.74M |
| Net Income | Q2 2021 · Jan 31, 2021 | −$48.3K |
| Net Income | Q2 2021 · Apr 30, 2020 | −$96.41K |
| Net Income | Q2 2021 · Apr 30, 2020 | −$222.7K |
| Net Income | Q2 2021 · Jan 31, 2020 | −$126.29K |
| Stockholders Equity | Q2 2021 · Nov 30, 2020 | $1.7M |
| Stockholders Equity restated | Q2 2021 · Apr 30, 2020 | −$359.63K |
| Stockholders Equity restated | Q2 2021 · Jan 31, 2020 | −$263.22K |
| Stockholders Equity | Q2 2021 · Nov 30, 2019 | −$136.93K |
| Shares Diluted restated | Q2 2021 · Apr 30, 2020 | 9.23M sh |
| Shares Diluted restated | Q2 2021 · Apr 30, 2020 | 9.23M sh |
| Cash And Equivalents | Q2 2021 · Apr 30, 2020 | $568.42K |
| Cash And Equivalents | Q2 2021 · Oct 31, 2019 | $1.18M |
| Operating Income | Q2 2021 · Apr 30, 2020 | −$99.02K |
| Operating Income restated | Q2 2021 · Apr 30, 2020 | −$229.6K |
| Revenue | Q2 2021 · Apr 30, 2020 | $21.53K |
| Revenue | Q2 2021 · Apr 30, 2020 | $21.53K |